Citius Oncology raises $18M in registered direct & private placement; funds LYMPHIR launch

CITIUS ONCOLOGY, INC.

Gross proceeds ~$18M from sale of 1,284,404 shares at $1.09 + 15,229,358 pre-funded warrants at $1.0899 per unit.
Net proceeds ~$15.2M after fees; H.C. Wainwright acted as placement agent (7% fee).
Concurrent private placement includes warrants exercisable at $1.09 upon stockholder approval, 5-year term.
Existing warrants for 11,961,040 shares amended to $1.09 exercise price and exercisable after stockholder approval.
Citius Pharma promissory note maturity amended to require $50M of gross proceeds raised before maturity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.